Wednesday, February 27, 2013

FDA OKs Roche drug for late-stage metastatic breast cancer

English: Breast and Cervical Cancer Screening Patients (Photo credit: Wikipedia)
(Reuters) – U.S. health regulators approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.
The U.S. Food and Drug...
FDA OKs Roche drug for late-stage metastatic breast cancer